Atea Pharmaceuticals, Inc. (AVIR)
3.945
-0.04
(-1.13%)
USD |
NASDAQ |
Nov 19, 16:00
3.945
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Price : 3.945 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 3.93 | 4.03 | 3.87 | 3.99 | 342251.0 |
| Nov 17, 2026 | 4.11 | 4.18 | 3.85 | 3.96 | 448461.0 |
| Nov 16, 2026 | 4.33 | 4.375 | 4.10 | 4.12 | 310622.0 |
| Nov 13, 2026 | 4.25 | 4.355 | 4.10 | 4.30 | 302689.0 |
| Nov 12, 2026 | 4.17 | 4.29 | 4.09 | 4.21 | 244197.0 |
| Nov 11, 2026 | 4.22 | 4.34 | 4.04 | 4.22 | 321530.0 |
| Nov 10, 2026 | 4.40 | 4.44 | 4.16 | 4.20 | 301495.0 |
| Nov 09, 2026 | 4.35 | 4.48 | 4.315 | 4.41 | 244274.0 |
| Nov 06, 2026 | 4.21 | 4.35 | 4.12 | 4.31 | 201579.0 |
| Nov 05, 2026 | 4.48 | 4.49 | 4.19 | 4.22 | 298412.0 |
| Nov 04, 2026 | 4.29 | 4.495 | 4.240 | 4.46 | 268908.0 |
| Nov 03, 2026 | 4.14 | 4.33 | 4.105 | 4.17 | 391298.0 |
| Nov 02, 2026 | 4.15 | 4.29 | 3.945 | 4.10 | 330310.0 |
| Oct 30, 2026 | 4.30 | 4.32 | 4.07 | 4.11 | 349864.0 |
| Oct 29, 2026 | 4.30 | 4.50 | 4.26 | 4.31 | 280875.0 |
| Oct 28, 2026 | 4.15 | 4.27 | 4.14 | 4.27 | 328415.0 |
| Oct 27, 2026 | 4.14 | 4.290 | 4.05 | 4.17 | 245240.0 |
| Oct 26, 2026 | 4.04 | 4.24 | 3.94 | 4.16 | 251086.0 |
| Oct 23, 2026 | 4.03 | 4.11 | 3.93 | 4.04 | 245442.0 |
| Oct 22, 2026 | 4.08 | 4.17 | 4.02 | 4.05 | 318759.0 |
| Oct 21, 2026 | 4.47 | 4.47 | 4.05 | 4.08 | 465228.0 |
| Oct 20, 2026 | 4.34 | 4.58 | 4.315 | 4.465 | 288829.0 |
| Oct 19, 2026 | 4.34 | 4.42 | 4.17 | 4.39 | 390039.0 |
| Oct 16, 2026 | 4.54 | 4.55 | 4.30 | 4.32 | 345876.0 |
| Oct 15, 2026 | 4.64 | 4.805 | 4.48 | 4.53 | 319365.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Filana Therapeutics, Inc. | 0.5517 |
| CorMedix, Inc. | 5.06 |
| Eloxx Pharmaceuticals, Inc. | 10.76 |
| Breakthrough Chemistry, Inc. | 0.0854 |
| BioStem Technologies, Inc. | 0.75 |
Price Related Metrics
| PEG Ratio | -0.1928 |
| Price to Book Value | 1.803 |
| Earnings Yield | -49.69% |
| Market Cap | 316.76M |
| PEGY Ratio | -0.1928 |